Results 211 to 220 of about 57,164 (280)

Remdesivir Versus Sotrovimab in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. [PDF]

open access: yesHealth Sci Rep
Khorramnia S   +9 more
europepmc   +1 more source

Efficacy of Remdesivir in Covid-19 Patients; Multicenter Study in Lahore [PDF]

open access: gold, 2020
Najeeb Ullah   +7 more
openalex   +1 more source

Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19. [PDF]

open access: yesSci Rep
Berry M   +12 more
europepmc   +1 more source

REMDESIVIR CAUSING PROFOUND BRADYCARDIA

open access: yesJournal of the American College of Cardiology, 2021
Saif Aldeen Al-Adwan   +3 more
openaire   +2 more sources

Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials. [PDF]

open access: yesBMJ Open
Yang C   +9 more
europepmc   +1 more source

Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center

open access: green, 2020
Jennifer A. McCoy   +4 more
openalex   +1 more source

Remdesivir and COVID-19 – Authors' reply [PDF]

open access: bronze, 2020
Yeming Wang   +4 more
openalex   +1 more source

Remdesivir inhibits endothelial activation and atherosclerosis by coupling TAL1 to TRAF6. [PDF]

open access: yesJ Transl Med
Zhang H   +8 more
europepmc   +1 more source

InVivoPharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters [PDF]

open access: green, 2020
Sawittree Sahakijpijarn   +7 more
openalex   +1 more source

The impact of remdesivir on renal and liver functions in severe COVID-19 patients with presence of viral load. [PDF]

open access: yesSci Rep
Waldauf P   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy